Drugmaker Novo Nordisk announced it is providing 340B covered entities 12-months-worth of refunds on four drug products including two of [...] …
Category: Pharma Industry
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maryland Gov. Wes Moore (D) this morning is signing legislation to make Maryland the sixth state to prohibit drugmaker 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
CVS Health recently cited drug manufacturers’ contract pharmacy restrictions as one of the causes for a 19% year-over-year income decline [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge scheduled an April 2025 trial date for AstraZeneca’s lawsuit against Arkansas’ 340B contract pharmacy access law as [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A California health system’s lawsuit alleging “hundreds of millions” in overcharges by four drugmakers was recently released from required mediation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Recently released draft guidance for implementing Medicare price caps would allow voluntary provider use of 340B codes on claims, while [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Pfizer announced it exempted Arkansas hospitals from its 340B contract pharmacy restrictions beginning this week. Effective May 6, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Novo Nordisk this week announced that its contract pharmacy restrictions will soon apply to all grantee covered entities—not just [...] …